ISAL 2019 | Progress in AML & research at the University of Düsseldorf

Thomas Schröder

Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses progress in acute myeloid leukemia (AML) and the ongoing research into myeloid disorders at his lab. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Share this video  
Similar topics